WEST HAVEN, Conn., Sept. 8, 2016 (GLOBE NEWSWIRE) -- Watson Inc. is proud to announce it will be a Gold Paw Sponsor of the 2016 Shoreline PuppyUp Walk. Watson also has a team participating in the walk with the goal to raise $5,000 for the charity. Watson would also like to encourage other local business to sponsor this event, and form a team of their own.
The 2016 Shoreline PuppyUp Walk will be held on October 30, from 11 AM to 3 Pm at the Guilford Fairgrounds on Lovers Lane in Guilford, Connecticut. This year, plans are underway to expand the vendor and craft area, food trucks, and silent auction. There will also be live music provided by The Elwoods . https://www.facebook.com/THE-ELWOODS-68940511705/
"Cancer is something that has touched nearly every one of us in some way. Over the years, we've supported both loved ones and employees in their battles against cancer and sadly we have lost too many. This is really a subject with which everyone can feel a connection. The PuppyUp Foundation is very unique, in that they fund research in comparative oncology. This is not a group that is solely funding research in canine cancer, it is much bigger in scope than that. Funds from the PuppyUp Foundation have funded research in both bone and bladder cancer, which potentially may result in treatment for human trials. The research model starts with dogs that already have preexisting cancer. Once treatments prove successful, they can progress to human studies." stated Moira Watson, Vice President of Marketing and Communications at Watson.
The PuppyUp Foundation maintains a Scientific Advisory Panel. The Foundation's scientific objectives are: Broadening our understanding of the links between human and companion-animal cancer, creating a cross-institutional collaborative platform, developing new approaches to research, and funding translational cancer studies that benefit both pets and people. A listing of PuppyUp Grant Recipients can be found here: http://www.puppyup.org/about-us/puppy-up-foundation-grants/
Watson has sponsored a walking team at the Shoreline PuppyUp Walk for three years, and is an advocate for local businesses to support their communities and give back.
Watson has a comprehensive community service program and is involved in local charities, as well as national charities and service organizations. To learn more about the community service programs at Watson, please see their News page: http://www.watson-inc.com/news/category/social-responsibility/
About PuppyUp:
The PuppyUp Foundation is committed to discovering the common links between canine and human cancers and the causes of these cancers through comparative oncology research. The PuppyUp Foundation was established to fund comparative and translational cancer studies that can potentially benefit both pets and people, as well as invest in national education and awareness initiatives about the epidemic of cancer in companion animals. Proposals of past recipients of grants have met the following criteria: collaborative and cross-institutional, and the scope of the research has focused on risk factors, drug delivery, and novel treatments and therapeutics. More information on PuppyUp can be found here: http://www.puppyup.org/
About Watson:
Watson is one of the highest-quality suppliers of products and services geared towards enhancing human health and nutrition around the world. We are a leader in developing quality products and innovative ingredient systems for the food and supplement industries. Expertise in custom nutrient premixes, microencapsulation, agglomeration, micronizing, spray drying, and film technology allows us to develop unique formulations and products using Watson-manufactured, value-added ingredients. For more information on Watson, see: www.watson-inc.com.
Contacts:
Watson Inc.
Moira Watson, V.P. Marketing & Communications
moira.watson@watson-inc.com
800-388-3481 or (203) 932-3000
Company info:
Watson Inc.
- Corporate headquarters: 301 Heffernan Drive, West Haven CT 06516
- CEO: James T. Watson
- Website: www.watson-inc.com
- Employees: 300
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=41352
